BOSTON, Dec. 4, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that Jennifer DiRico has been appointed Executive Vice President and Chief Financial Officer, effective January 1, 2026. DiRico ...

PTC Therapeutics boasts a robust rare disease portfolio, strong cash position, and recent profitability but faces key regulatory and royalty risks. PTCT's near-term upside hinges on FDA approval for ...

* Investments in securities are subject to market risks. These are indicative and should not be interpreted as investment advice or guaranteed returns.

PTC Mathcad is the industry standard for engineering calculation software, providing a comprehensive platform for performing, documenting, and sharing technical calculations. Unlike spreadsheets or ...

With strong share price gains and significant hedge fund interest, PTC Inc. (NASDAQ:PTC) secures a spot on our list of the 11 Hot Software Stocks to Buy Now. A person using a laptop with a blue ...

Power trading solutions provider PTC India Ltd on Thursday (August 7) reported a 44.4% year-on-year (YoY) jump in net profit at ₹195 crore for the first quarter that ended June 30, 2025. In the ...

BOSTON, July 30, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that it is expanding the scope of its collaboration with NVIDIA, the world leader in accelerated computing. PTC is integrating ...

Investing.com - UBS has reiterated a Buy rating and $71.00 price target on PTC Therapeutics (NASDAQ:PTCT), currently trading at $49.85, ahead of the company’s upcoming FDA decision for sepiapterin, a ...

The proposed final dividend of ₹6.70 per fully paid-up equity share, each having a face value of ₹10, signifies the company's commitment to shareholder returns. If declared at the AGM, the dividend ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...